Recent News

• 04.17.2025 - Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC
• 04.08.2025 - Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities
• 03.18.2025 - Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI
• 02.28.2025 - Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

Recent Filings

• 04.17.2025 - EX-99.1 EX-99.1
• 04.17.2025 - 8-K Current report
• 04.11.2025 - 8-K Current report
• 04.03.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 04.03.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 04.02.2025 - EFFECT Notice of Effectiveness
• 03.31.2025 - S-3/A Registration statement under Securities Act of 1933
• 03.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.18.2025 - EX-99.1 EX-99.1
• 03.18.2025 - 425 Prospectuses and communications, business combinations